LPA1 antagonist-derived LNPs deliver A20 mRNA and promote anti-fibrotic activities
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
LPA1 antagonist-derived LNPs deliver A20 mRNA and promote anti-fibrotic activities ; day:27 ; month:6 ; year:2024 ; pages:1-8
Nano research ; (27.6.2024), 1-8
- Creator
-
Yan, Jingyue
Kang, Diana D.
Wang, Chang
Hou, Xucheng
Du, Shi
Wang, Siyu
Xue, Yonger
Liu, Zhengwei
Li, Haoyuan
Zhong, Yichen
Deng, Binbin
McComb, David W.
Dong, Yizhou
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12274-024-6747-6
- URN
-
urn:nbn:de:101:1-2409180840198.674650248890
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yan, Jingyue
- Kang, Diana D.
- Wang, Chang
- Hou, Xucheng
- Du, Shi
- Wang, Siyu
- Xue, Yonger
- Liu, Zhengwei
- Li, Haoyuan
- Zhong, Yichen
- Deng, Binbin
- McComb, David W.
- Dong, Yizhou
- SpringerLink (Online service)
Other Objects (12)
Adhesive anti-fibrotic interfaces on diverse organs
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Development and characterization of anti-fibrotic natural compound similars with improved effectivity
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence
Adhesive anti-fibrotic interfaces on diverse organs
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Development and characterization of anti-fibrotic natural compound similars with improved effectivity
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence
Adhesive anti-fibrotic interfaces on diverse organs
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Development and characterization of anti-fibrotic natural compound similars with improved effectivity
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis